Prednisone

• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig… Not authorised
  2024-511181-36-00 Phase III 1 country Beacon Therapeutics (USA) Inc.
• Corticoid Therapy in Acute Myocarditis Pending
  2024-510602-90-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Sarilumab efficacy and safety in adults with early polymyalgia rheumatica Pending
  2024-511296-15-00 Phase III 9 countries Sanofi-Aventis Recherche & Developpement
• A Phase II Open Label Study of Brentuximab Vedotin in Combination with CHEP in Patients with Previously Untreated CD30-expressing Peripheral… Pending
  2024-511567-28-01 Phase II 1 country Kooperativni Lymfomova Skupina z.s.
• Severe Erythema Multiforme - CORTICO Pending
  2024-516018-39-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Bosentan in the treatment of Giant Cell Arteritis Pending
  2024-517030-17-00 Phase II 1 country Assistance Publique Hopitaux De Paris
• A PROJECT FOR TWO MULTICENTRE, PROSPECTIVE OPEN LABEL RANDOMIZED CLINICAL STUDIES TO EVALUATE THE EFFECT OF TARGETED THERAPY BASED ON KIDNEY… Pending
  2024-517861-18-00 Phase III 1 country Fondazione Schena Centro Europeo Della Ricerca Sulle Malattie Renali
• RANDOMIZED, CONTROLLED, OPEN TRIAL OF TWO STANDARDIZED DECLINE SCHEMES, FAST (NORTH AMERICAN) AND SLOW (EUROPEAN) RESPECTIVELY, OF CORTISONE… Pending
  2024-518653-41-00 Phase III 1 country Centre Hospitalier Universitaire De Caen Normandie
• MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLE… Pending
  2025-520884-42-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• CHILURSO: Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy Pending
  2025-521317-50-00 Phase III 1 country Centre Hospitalier Universitaire De Montpellier
• A single arm study to investigate OCS tapering in adult participants with generalized Myasthenia Gravis treated with ravulizumab Pending
  2025-522555-26-00 Phase IV 2 countries Alexion Pharmaceuticals Inc.
• Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease Recruiting
  2025-521408-24-00 Phase III 1 country Medical University Of Lodz
• A Phase 1/2 study of ALXN2350 in adult participants with BAG3-associated dilated cardiomyopathy Recruiting
  2024-519674-40-00 Phase I (FiH) 3 countries Alexion Pharmaceuticals Inc.
• Multicenter, Open-Label, Randomized Study of Nipocalimab or IVIG in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (F… Recruiting
  2023-509434-19-00 Phase III 4 countries Janssen Cilag International
• Steroid withdrawal in SLE Recruiting
  2024-518580-35-00 Phase IV 1 country Azienda Ospedaliero Universitaria Pisana
• Glucocorticoids versus placebo for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a randomized controlled trial Recruiting
  2024-514799-42-00 Phase II 1 country GIE Groupe hospitalier Paris Saint-Joseph/Vinci
• Open-label, Phase 3 Gene Delivery Study with SRP-9003 in LGMD 2E/R4 Subjects Recruiting
  2022-503112-17-00 Phase III 4 countries Sarepta Therapeutics Inc.
• A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting
  2022-502660-20-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN … Recruiting
  2022-502739-20-00 Phase III 10 countries Pfizer Inc.
• This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting
  2023-505277-32-00 Phase III 16 countries AbbVie Deutschland GmbH & Co. KG
• Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting
  2022-502503-30-00 Phase III 19 countries Princess Maxima Center For Pediatric Oncology
• Evaluation of the efficacy of corticosteroids in septic arthritis in adults: Randomized double-blind controlled trial [CORSAR] Recruiting
  2025-522193-37-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock … Recruiting
  2024-518493-14-00 Phase II/III 1 country Les Hopitaux Universitaires De Strasbourg
• A clinical trial to learn about the effects of AMO959 given with AAA617 and an androgen receptor pathway inhibitor (ARPI) in adults with PSM… Recruiting
  2025-521859-23-00 Phase I/II 4 countries Novartis Pharma AG

Showing 1–24 of 128 trials